Asensus Surgical, Inc.
ASXC · AMEX
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $2 | $1 | $5 | $1 |
| % Growth | 96.5% | -79.3% | 398.7% | – |
| Cost of Goods Sold | $3 | $3 | $4 | $3 |
| Gross Profit | -$1 | -$2 | $1 | -$2 |
| % Margin | -25.5% | -182.3% | 19.4% | -163.5% |
| R&D Expenses | $8 | $8 | $9 | $9 |
| G&A Expenses | $6 | $4 | $4 | $5 |
| SG&A Expenses | $10 | $8 | $8 | $9 |
| Sales & Mktg Exp. | $4 | $4 | $4 | $4 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $16 | $16 | $18 |
| Operating Income | -$24 | -$18 | -$16 | -$20 |
| % Margin | -1,066.7% | -1,616.6% | -294.6% | -1,816.3% |
| Other Income/Exp. Net | -$5 | -$4 | -$2 | $2 |
| Pre-Tax Income | -$26 | -$22 | -$17 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$26 | -$22 | -$17 | -$18 |
| % Margin | -1,166.7% | -2,003.3% | -317.3% | -1,682.1% |
| EPS | -0.095 | -0.08 | -0.065 | -0.072 |
| % Growth | -18.3% | -22.7% | 8.8% | – |
| EPS Diluted | -0.095 | -0.08 | -0.065 | -0.072 |
| Weighted Avg Shares Out | 272 | 269 | 264 | 256 |
| Weighted Avg Shares Out Dil | 272 | 269 | 264 | 256 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$24 | -$17 | -$16 | -$17 |
| % Margin | -1,105.7% | -1,531.5% | -295.9% | -1,597.2% |